Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

News

No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY

Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on lopinavir-ritonavir, 29 June 2020

Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19

Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on dexamethasone, 16 June 2020

No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19

Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020

First patient, a child, receives convalescent plasma through RECOVERY, the dedicated COVID-19 treatment trial

Recruitment to the RECOVERY Trial continues as planned

RECOVERY team reflect on International Clinical Trials Day 2020

RECOVERY Trial rolled out across the UK

Letter from Chief Medical Officers encourages participation in COVID-19 trials

Oxford's COVID-19 research receives government funding

First patients enrolled in new clinical trial of possible COVID-19 treatments